3.44
+0.02(+0.58%)
Currency In USD
| Previous Close | 3.42 |
| Open | 3.26 |
| Day High | 3.46 |
| Day Low | 3.26 |
| 52-Week High | 175.98 |
| 52-Week Low | 3.09 |
| Volume | 44,039 |
| Average Volume | 230,712 |
| Market Cap | 391,565 |
| PE | -0.01 |
| EPS | -313.92 |
| Moving Average 50 Days | 4.36 |
| Moving Average 200 Days | 27.44 |
| Change | 0.02 |
If you invested $1000 in Nuwellis, Inc. (NUWE) 10 years ago, it would be worth $0 as of October 19, 2025 at a share price of $3.44. Whereas If you bought $1000 worth of Nuwellis, Inc. (NUWE) shares 5 years ago, it would be worth $0 as of October 19, 2025 at a share price of $3.44.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Nuwellis Announces 92% Survival in Children with Acute Kidney Injury (AKI), Fluid Overload or Congenital Kidney Failure Following Treatment with Aquadex®
GlobeNewswire Inc.
Sep 30, 2025 12:45 PM GMT
ULTRA-Peds Registry, the largest multi-center dataset of its kind, shows Aquadex therapy was well-tolerated in critically ill children, a population with extremely limited treatment options Results highlight life-threatening gaps in pediatric care an
Nuwellis Receives New US Patent Reinforcing Vivian™ Pediatric Device Focused on Safer, More Precise Ultrafiltration
GlobeNewswire Inc.
Sep 18, 2025 1:00 PM GMT
EDEN PRAIRIE, Minn., Sept. 18, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc., a fluid management company, today announced that the United States Patent and Trademark Office has issued U.S. Patent No. 12,415,021 on September 16, 2025, based on Application
Nuwellis, Inc. Participates in a Virtual Investor “What This Means” Segment
GlobeNewswire Inc.
Sep 17, 2025 2:16 PM GMT
Watch the “What This Means” segment here MINNEAPOLIS, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company delivering fluid management solutions for critically ill patients, today announced that it particip